根据监管文件显示，Tourmaline Bio披露了与Novartis合并协议中的重要条款。文件显示，如果双方的合并交易在特定情况下被终止，Novartis将需要向Tourmaline Bio支付6850万美元的终止费用。
这一终止费条款为Tourmaline Bio在合并交易可能失败的情况下提供了一定的财务保障，确保公司能够获得相应的补偿。该条款的具体触发条件和执行细节已在相关监管文件中详细说明。
根据监管文件显示，Tourmaline Bio披露了与Novartis合并协议中的重要条款。文件显示，如果双方的合并交易在特定情况下被终止，Novartis将需要向Tourmaline Bio支付6850万美元的终止费用。
这一终止费条款为Tourmaline Bio在合并交易可能失败的情况下提供了一定的财务保障，确保公司能够获得相应的补偿。该条款的具体触发条件和执行细节已在相关监管文件中详细说明。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.